MacroGenics | MGNX - Interest Expense On Debt


MacroGenics reported $3.34M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 303M 38M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Daiichi Sankyo JPY 2.16B 1.33B Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Genmab DKK 37M 28M Sep/2025
Geron USD 8.64M 128K Sep/2025
Gilead Sciences USD 254M 6M Jun/2025
J&J USD 18M 290M Sep/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Merck USD 412M 85M Dec/2025
Pfizer USD 711M 59M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Xencor USD 7.66M 578K Sep/2025